NCT05012852 - Evaluation of VagiVitalAC for Treatment of Candida Vulvovaginitis | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

February 28, 2022

Study Completion Date

June 30, 2022

Conditions

Vaginal CandidiasisVulvovaginal CandidiasisCandidal Vulvovaginitis

Interventions

DEVICE

VagiVitalAC

In the Pilot part, the single intervention used is VagiVitalAC treatment for 30 days. In the randomized part, patients in the Interventional arm are treated with VagiVital AC for up to 90 days.

Trial Locations (1)

Unknown

RECRUITING

Karolinska University Hospital, Huddinge